Rhythm Pharmaceuticals (RYTM) Common Equity (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Common Equity of $102.98 million for Q2 2026, compared with -$11.91 million a year earlier and down 16.2% from the prior quarter.
Rhythm Pharmaceuticals (RYTM) Common Equity (2016 - 2026) Analysis & Trends
At the end of FY2025, Rhythm Pharmaceuticals posted Common Equity of $139.07 million, up 540.0% from FY2024.
- Common Equity has a five-year compound annual growth rate of -3.5% (FY2020 to FY2025).
- By year, Common Equity came in at $21.73 million in FY2024 (-87.2%), $169.76 million in FY2023 (-35.8%), $264.26 million in FY2022 (-7.0%) and $284.15 million in FY2021 (+70.6%).
- Five-year quarterly Common Equity spans a low of -$11.91 million in Q2 2025 and a high of $322.26 million in Q3 2021.
- Year over year, Common Equity gained in two of the last five quarters, with growth averaging 167.6%.
- The high point for year-over-year Common Equity in five years was Q1 2026 (growth of 548.7%); the low point was Q3 2024 (a decline of 94.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $122.91 million (Q1 2026), $139.07 million (Q4 2025) and $148.82 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Rhythm Pharmaceuticals | 6.14 Bn | 5.01 Bn | 62.32 Mn | 102.98 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 102.98 Mn |
| Mar 31, 2026 | 122.91 Mn |
| Dec 31, 2025 | 139.07 Mn |
| Sep 30, 2025 | 148.82 Mn |
| Jun 30, 2025 | -11.91 Mn |
| Mar 31, 2025 | 18.95 Mn |
| Dec 31, 2024 | 21.73 Mn |
| Sep 30, 2024 | 11.22 Mn |
| Jun 30, 2024 | 39.34 Mn |
| Mar 31, 2024 | 61.58 Mn |
| Dec 31, 2023 | 169.76 Mn |
| Sep 30, 2023 | 197.47 Mn |
| Jun 30, 2023 | 182.29 Mn |
| Mar 31, 2023 | 219.76 Mn |
| Dec 31, 2022 | 264.26 Mn |
| Sep 30, 2022 | 281.20 Mn |
| Jun 30, 2022 | 195.63 Mn |
| Mar 31, 2022 | 235.77 Mn |
| Dec 31, 2021 | 284.15 Mn |
| Sep 30, 2021 | 322.26 Mn |
Rhythm Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RYTM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();